Clinical trial
Evaluation of PSMA-based PET as an Imaging Biomarker of Primary Prostate Cancer
NCT01496157 is registered in ClinicalTrials.gov with Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of PSMA-based PET as an Imaging Biomarker of Primary Prostate Cancer
- Lead sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- September 11, 2012
- Completion date
- September 17, 2017
- Enrollment
- 15 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer